CID 134817268

Ghrelin agonist hm01

Structural Information

Molecular Formula
C19H29Cl2N3O2
SMILES
C[C@H](C1=C(C(=C(C=C1)OC)Cl)Cl)NC(=O)N(C)[C@H]2CCN(CC2(C)C)C
InChI
InChI=1S/C19H29Cl2N3O2/c1-12(13-7-8-14(26-6)17(21)16(13)20)22-18(25)24(5)15-9-10-23(4)11-19(15,2)3/h7-8,12,15H,9-11H2,1-6H3,(H,22,25)/t12-,15+/m1/s1
InChIKey
WGIAKIIMCPKJQN-DOMZBBRYSA-N
Compound name
3-[(1R)-1-(2,3-dichloro-4-methoxyphenyl)ethyl]-1-methyl-1-[(4S)-1,3,3-trimethylpiperidin-4-yl]urea
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

9
References

12
Patents

401.1637 Da
Monoisotopic Mass

4.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 402.17098 192.4
[M+Na]+ 424.15292 198.7
[M-H]- 400.15642 198.1
[M+NH4]+ 419.19752 206.2
[M+K]+ 440.12686 194.7
[M+H-H2O]+ 384.16096 186.1
[M+HCOO]- 446.16190 201.3
[M+CH3COO]- 460.17755 230.6
[M+Na-2H]- 422.13837 189.6
[M]+ 401.16315 196.1
[M]- 401.16425 196.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.